Business Description
AgeX Therapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US00848H1086
Description
AgeX Therapeutics Inc is a biotechnology company engaged in the development and commercialization of novel therapeutics targeting human aging. The firm through its PureStem and induced Tissue Regeneration (iTR) technologies develops medicines designed to address some of the unsolved problems in aging. Its PureStem-derived cell-based therapeutic candidates in development are AGEX-VASC1, AGEX-BAT1 and AGEX-iTR1547.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.08 | |||||
| Equity-to-Asset | 0.46 | |||||
| Debt-to-Equity | 0.8 | |||||
| Debt-to-EBITDA | -0.45 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | -16.05 | |||||
| Beneish M-Score | 1.3 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 138.7 | |||||
| 3-Year EBITDA Growth Rate | -238.1 | |||||
| 3-Year EPS without NRI Growth Rate | -266.2 | |||||
| 3-Year FCF Growth Rate | -225.2 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 61.05 | |||||
| 9-Day RSI | 60.67 | |||||
| 14-Day RSI | 58.86 | |||||
| 6-1 Month Momentum % | -52.96 | |||||
| 12-1 Month Momentum % | -43.39 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.13 | |||||
| Quick Ratio | 0.13 | |||||
| Cash Ratio | 0.06 | |||||
| Days Sales Outstanding | 71.97 | |||||
| Days Payable | 7967.95 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.2 | |||||
| Shareholder Yield % | -10.17 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 71.83 | |||||
| Operating Margin % | -7014.09 | |||||
| Net Margin % | -10424.65 | |||||
| FCF Margin % | -5522.9 | |||||
| ROA % | -141.73 | |||||
| ROIC % | -47.72 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 84.73 | |||||
| PB Ratio | 2.19 | |||||
| Price-to-Tangible-Book | 2.46 | |||||
| EV-to-EBIT | -3.21 | |||||
| EV-to-EBITDA | -3.25 | |||||
| EV-to-Revenue | 223.79 | |||||
| EV-to-FCF | -4.07 | |||||
| Earnings Yield (Greenblatt) % | -31.15 | |||||
| FCF Yield % | -28.1 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
AgeX Therapeutics Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.131 | ||
| EPS (TTM) (€) | -12.779 | ||
| Beta | 0 | ||
| Volatility % | 78.18 | ||
| 14-Day RSI | 58.86 | ||
| 14-Day ATR (€) | 0.495181 | ||
| 20-Day SMA (€) | 13.030484 | ||
| 12-1 Month Momentum % | -43.39 | ||
| 52-Week Range (€) | 10.550999 - 38.686999 | ||
| Shares Outstanding (Mil) | 2.5 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
AgeX Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
AgeX Therapeutics Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
AgeX Therapeutics Inc Frequently Asked Questions
What is AgeX Therapeutics Inc(STU:0X40)'s stock price today?
The current price of STU:0X40 is €13.72. The 52 week high of STU:0X40 is €38.69 and 52 week low is €10.55.
When is next earnings date of AgeX Therapeutics Inc(STU:0X40)?
The next earnings date of AgeX Therapeutics Inc(STU:0X40) is 2025-03-01 Est..
Does AgeX Therapeutics Inc(STU:0X40) pay dividends? If so, how much?
AgeX Therapeutics Inc(STU:0X40) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers